Trial reportAnnals of surgery2026
Impact of Hypovolemic Phlebotomy With Low Central Venous Pressure on Intraoperative Blood Loss in Open Liver Resection: A Double-Blind Randomized Controlled Trial.
Trial report in Annals of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Outcomes After Intraoperative Hypovolemic Phlebotomy in Patients Undergoing Liver Surgery: A Meta-Analysis.World journal of surgery · 2026Pooled it
- Safety and outcomes of hemodilutional autologous transfusion in intermediate- to advanced-level liver resection: a prospective observational study.Surgery today · 2026Article
- Hypovolemic phlebotomy and low central venous pressure: a paradigm shift in liver surgery?Hepatobiliary surgery and nutrition · 2026Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess the efficacy and safety of hypovolemic phlebotomy (HP) versus conventional management (control group) in achieving low central venous pressure (CVP) to reduce blood loss during open liver resections.
backgroundExcessive blood loss increases perioperative complications and worsens patient outcomes. HP is used to reduce blood loss and the need for allogenic transfusions. This study compares intraoperative blood loss between HP and conventional techniques in liver resection.
methodsThis prospective, randomized controlled trial, conducted between 2020 and 2024, evaluated intraoperative blood loss as the primary endpoint, with secondary endpoints of allogenic transfusion and postoperative outcomes.
resultsOne hundred participants were randomized to either the HP or control groups, with similar baseline characteristics. The HP group had significantly lower blood loss during parenchymal transection [300 (250-500) vs. 500 (300-750) mL, difference=150, 95% CI: 50-275; P =0.02], shorter time to achieve low CVP [50 (30-100) vs. 107.5 (45-150) minutes, difference=-75.0, 95% CI: -95.0 to -56.0; P = 0.01], and a lower surgical bleeding score [2 (1-3) vs. 2 (2-4), difference=-1.0, 95% CI: -1.0 to -0.5; P =0.01]. Transfusion rates and postoperative complications were similar. HP was an independent protective against blood loss >500 mL (AOR=0.19, 95% CI: 0.04-0.80; P =0.02).
conclusionsHP significantly reduces intraoperative blood loss and enhances bleeding control by achieving a low CVP more quickly. It is an effective technique for minimizing blood loss and improving outcomes in open liver resections.
Indexed as
Identifiers
40396243What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.